<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Placenta growth factor (PlGF) is a member of the vascular endothelial growth factor (VEGF) family </plain></SENT>
<SENT sid="1" pm="."><plain>PlGF is implicated in several pathologic processes, including the growth and spread of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to evaluate the expression and the clinical implications of PlGF in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: In order to ascertain the clinical significance of PlGF expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, the researcher analyzed the expression pattern of PlGF by using an immunohistochemical method and attempted to establish if a relationship existed between PlGF expression and microvessel density (MVD), and subsequently between PlGF expression and the predicted prognosis </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 83 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> were included for immunohistochemical staining </plain></SENT>
<SENT sid="5" pm="."><plain>Clinicopathological characteristics were defined according to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-node-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (TNM) criteria of the Union for International <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Control </plain></SENT>
<SENT sid="6" pm="."><plain>Clinicopathologic factors, such as age, sex, histological types of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell grade, TNM stage, lymphovascular invasion, and lymph-node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, were reviewed </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: In this study, the PlGF protein expression level was significantly correlated with MVD, patient survival, and clinicopathological factors such as lymph-node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, TNM staging, lymphatic invasion and vascular invasion </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: PlGF may be an important angiogenic factor in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and in this study, PlGF expression level was significantly correlated with positive <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph-node metastases</z:e>, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage, and patient survival </plain></SENT>
<SENT sid="9" pm="."><plain>These findings suggest that PlGF expression correlates with disease progression and may be used as a prognostic marker for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>